TherapeuticsMD Inc. (TXMD)
NASDAQ: TXMD
· Real-Time Price · USD
1.41
0.17 (13.71%)
At close: May 01, 2025, 3:58 PM
1.39
-1.40%
After-hours: May 01, 2025, 04:00 PM EDT
13.71% (1D)
| Bid | 1.36 |
| Market Cap | 16.32M |
| Revenue (ttm) | 1.76M |
| Net Income (ttm) | -2.18M |
| EPS (ttm) | -0.2 |
| PE Ratio (ttm) | -7.05 |
| Forward PE | 7.38 |
| Analyst | n/a |
| Ask | 1.43 |
| Volume | 190,311 |
| Avg. Volume (20D) | 294,596 |
| Open | 1.27 |
| Previous Close | 1.24 |
| Day's Range | 1.26 - 1.48 |
| 52-Week Range | 0.70 - 2.44 |
| Beta | 0.95 |
About TXMD
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone...
Sector Healthcare
IPO Date May 9, 2007
Employees 1
Stock Exchange NASDAQ
Ticker Symbol TXMD
Website https://www.therapeuticsmd.com
